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Herpes simplex virus type 1 utilizes cell surface hepa-
ran sulfate as receptors to infect target cells. The unique
heparan sulfate saccharide sequence offers the binding
site for viral envelope proteins and plays critical roles in
assisting viral infections. A specific 3-O-sulfated hepa-
ran sulfate is known to facilitate the entry of herpes
simplex virus 1 into cells. The 3-O-sulfated heparan sul-
fate is generated by the heparan sulfate D-glucosaminyl-
3-O-sulfotransferase isoform 3 (3-OST-3), and it provides
binding sites for viral glycoprotein D (gD). Here, we
report the purification and structural characterization
of an oligosaccharide that binds to gD. The isolated gD-
binding site is an octasaccharide, and has a binding
affinity to gD around 18 M, as determined by affinity
coelectrophoresis. The octasaccharide was prepared
and purified from a heparan sulfate oligosaccharide li-
brary that was modified by purified 3-OST-3 enzyme.
The molecular mass of the isolated octasaccharide was
determined using both nanoelectrospray ionization
mass spectrometry and matrix-assisted laser desorp-
tion/ionization mass spectrometry. The results from the
sequence analysis suggest that the structure of the oc-
tasaccharide is a heptasulfated octasaccharide. The pro-
posed structure of the octasaccharide is UA-GlcNS-
IdoUA2S-GlcNAc-UA2S-GlcNS-IdoUA2S-GlcNH23S6S.
Given that the binding of 3-O-sulfated heparan sulfate to
gD can mediate viral entry, our results provide struc-
tural information about heparan sulfate-assisted viral
entry.
Heparan sulfates (HS),1 highly sulfated polysaccharides, are
present on the surface of mammalian cells and in the extracel-
lular matrix in large quantities. HS play critical roles in a
variety of biological interactions, including assisting viral in-
fection, regulating blood coagulation and embryonic develop-
ment, suppressing tumor growth, and controlling the eating
behavior of mice by interacting with specific regulatory pro-
teins (1–5). HS is initially synthesized as a copolymer of glu-
curonic acid and N-acetylated glucosamine by D-glucuronyl and
N-acetyl-D-glucosaminyl transferase, followed by various mod-
ifications (6). These modifications include C5-epimerization of
glucuronic acid to form iduronic acid residues, 2-O-sulfation of
iduronic and glucuronic acid, N-deacetylation and N-sulfation
of glucosamine, as well as 6-O-sulfation and 3-O-sulfation of
glucosamine. Numerous HS biosynthetic enzymes have been
cloned and characterized (for review, see Esko and Lindahl (7)).
The specific sulfated saccharide sequences play critical roles
in determining the functions of HS. A recent report suggests
that the expression levels of various isoforms of each class of
HS biosynthetic enzyme contribute to the synthesis of specific
saccharide sequences in specific tissues (8). HS N-deacetylase/
N-sulfotransferase, 3-O-sulfotransferase, and 6-O-sulfotrans-
ferase are present in multiple isoforms, and each isoform is
believed to recognize the saccharide sequence around the mod-
ification site to generate a specific sulfated saccharide sequence
(8–10). For instance, HS D-glucosaminyl-3-O-sulfotransferase
(3-OST) isoforms generate 3-O-sulfated glucosamine that is
linked to different sulfated uronic acid residues. 3-OST-1 trans-
fers sulfate to the 3-OH position of the N-sulfated glucosamine
residue that is linked to a glucuronic acid residue at the non-
reducing end (GlcUA-GlcNS  6S), whereas, 3-OST-3 transfers
sulfate to the 3-OH position of the N-unsubstituted glucosa-
mine residue that is linked to a 2-O-sulfated iduronic acid at
the nonreducing end (IdoUA2S-GlcNH2  6S) (11). The differ-
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ence in substrate specificity of 3-OSTs results in distinct bio-
logical functions of the HS modified by 3-OSTs. For example,
HS modified by 3-OST-1 binds to antithrombin and has anti-
coagulant activity (12), whereas the HS modified by 3-OST-3
binds to herpes simplex 1 envelope glycoprotein D (gD) and
assists in viral entry (13).
Herpes simplex virus type 1 (HSV-1) is a member of the
herpesvirus family, and infection in humans is prevalent.
HSV-1 infection requires a two-step process that can be sepa-
rated experimentally: attachment to cells and entry into cells
(14). It is now known that HS is involved in assisting viral
binding as well as viral entry (15). HSV-1 binds to host cells
through an interaction of virion envelope glycoprotein C (gC),
or in some cases of glycoprotein B (gB), with HS (16–18).
Structural analysis of gC-binding HS revealed that a minimum
of 10–12 sugar residues containing IdoUA2S and GlcNS(or
Ac)6S are necessary (19), and this conclusion was confirmed by
another study (20).
A recent report suggests that a specific 3-O-sulfated HS is
involved in assisting HSV-1 entry (13). The 3-O-sulfated HS is
generated by 3-OST-3, but not by 3-OST-1. It should be noted
that 3-OST-3-modified HS is rarely found in HS from natural
sources, suggesting that HSV-1 recognizes a unique saccharide
structure (11). In addition, a biochemical study revealed that
3-O-sulfated HS provides binding sites for HSV-1 envelope
glycoprotein gD, which is a key viral protein involved in entry
of HSV-1. It is believed that the interaction between gD and the
3-O-sulfated HS triggers the fusion between the virus and the
cell in the presence of other viral envelope proteins, including
gB, gH, and gL, via an uncharacterized mechanism. The study
of the crystal structure of gD and herpes entry receptor HveA
suggest that the binding of HveA to gD induces conformational
changes in gD (21). This study also predicts a 3-O-sulfated
HS-binding pocket on gD near the HveA-binding site (21). The
exact carbohydrate sequence of the gD-binding site in 3-O-
sulfated HS remains to be investigated.
In this article, we report the characterization of the structure
of a gD-binding octasaccharide. The results from extensive
sequencing analysis suggest that the structure of the gD-bind-
ing octasaccharide is UA-GlcNS-IdoUA2S-GlcNAc-UA2S-
GlcNS-IdoUA2S-GlcNH23S6S (residue 1 is GlcNH23S6S and
residue 8 is UA). The octasaccharide apparently has two
motifs: a relatively low sulfation domain (residues 5–8) that
contains two sulfate groups and a high sulfation domain (res-
idue 1 to residue 4) that contains five sulfate groups. Although
we still do not know the contribution of each sulfate group to
the binding affinity of the octasaccharide and gD, the results
from this study will provide the structural information to un-
derstand HS-assisted viral infection mechanisms.
EXPERIMENTAL PROCEDURES
Materials
Recombinant 3-OST-3A and 3-OST-1 enzymes were expressed in Sf9
cells using baculovirus expression system. The enzymes were purified
by using heparin-Toyopearl and 3,5-ADP-agarose chromatographies
as described previously (11, 22). [35S]PAPS was prepared by incubating
0.4 mCi/ml [35S]Na2SO4 (carrier-free, ICN) and 16 mM ATP with 5
mg/ml dialyzed yeast extract (Sigma) (12). Iduronate-2-sulfatase, -idu-
ronidase, -N-acetylglucosaminidase, glucosamine-6-sulfatase, and sul-
famidase were obtained from Glyko. Recombinant heparin lyase I (EC
4.2.2.7), II (no EC number), and III (E.C. 4.2.2.8) were prepared as
described previously (23). 4,5-Glycuronidase was isolated from Fla-
vobacterium heparinum (24). HS from bovine kidney was obtained from
ICN. A truncated form of herpes simplex virus 1 glycoprotein D, gD-1-
(306t), and monoclonal anti-gD-(DL6) were prepared as previously
described (25).
Preparation of gD-binding Octasaccharide
Preparation of the HS Oligosaccharide Library—The library was
prepared by incubating HS with limited amounts of heparin lyase III
followed by size fractionation on a Bio-Gel P-6 (Bio-Rad) column as
described by Pye et al. (26). In a typical preparation, HS from bovine
kidney (1 mg) was incubated with 2 milliunits of heparin lyase III in 1
ml of buffer containing 50 mM sodium phosphate and 100 g/ml bovine
serum albumin, pH 7.0, at 37 °C overnight. The digestion was termi-
nated by heating at 100 °C for 15 min. The sample was then loaded on
a Bio-Gel P-6 (0.75  200 cm) equilibrated with 0.5 M ammonium
bicarbonate at a flow rate of 5 ml/h and 0.5-ml fractions were collected.
The absorbance at 232 nm was measured for each fraction. Peaks
corresponding to tetra- to greater than dodecasaccharides were pooled
individually, and dialyzed against 50 mM ammonium bicarbonate using
MWCO 3,500 membrane. Each pool was dried on a Speed-Vac concen-
trator (Labconco) and reconstituted in 50 l of water. The optical
density (232 nm) of the resultant solution was about 3. We processed a
total of 40 mg of HS to obtain a sufficient amount of gD-binding
octasaccharide for the structural analysis.
Preparation of 3-O-Sulfated Oligosaccharides—To prepare 3-OST-
3A-modified HS oligosaccharide, 20 l of the oligosaccharide library or
intact HS (1 g) was mixed with 240 ng of purified 3-OST-3A enzyme
and 10 M [35S]PAPS (14,000 dpm/pmol) in a buffer containing 50 mM
MES, 1% Triton X-100, 1 mM MgCl2, 2 mM MnCl2, 150 mM NaCl, and
168 g/ml bovine serum albumin, pH 7, in a final volume of 50 l. The
reaction was incubated at 37 °C for 2 h and was then heated at 100 °C
for 2 min. The resultant solution was centrifuged at 14,000 rpm for 1
min to remove insoluble materials. The supernatant was dialyzed
against 50 mM ammonium bicarbonate using MWCO 3,500 membrane
and dried. To prepare 3-OST-1-modified oligosaccharides, we followed
nearly identical procedures except for omitting the 150 mM NaCl and
using 70 ng of 3-OST-1 enzyme during the enzymatic modification
reaction.
Purification of the 3-O-Sulfated Octasaccharides by HPLCs—The
3-OST-3-modified oligosaccharides were applied to a silica-based poly-
amine (PAMN) HPLC column (0.46  25 cm, Waters). The column was
eluted with a linear gradient of KH2PO4 from 350 mM to 1 M for 60 min
followed by an additional wash with 1 M KH2PO4 for 20 min at a flow
rate of 1 ml/min (11). The fractions containing 35S-radioactivity were
pooled separately and resolved on Bio-Gel P-6. The fractions were
dialyzed against 25 mM ammonium acetate using MWCO 3,500 mem-
brane and dried. They were further purified by DEAE-NPR HPLC
chromatography (0.46  7.5 cm, Tosohaas). The DEAE-NPR column
was eluted with a linear gradient of NaCl in 50 mM Tris-HCl, pH 7, from
100 to 500 mM in 60 min followed by an additional wash for 20 min
with 1 M NaCl in 50 mM Tris-HCl, pH 7, at a flow rate of 0.5 ml/min.
The eluted oligosaccharides were monitored by 35S-radioactivity and
the absorbance at 232 nm. We obtained about 200 to 300 pmol of
purified 35S-labeled oligosaccharides from 20 mg of HS that was
partially digested with heparin lyase III. We did observe a UV peak
that overlapped with the 35S-radioactive peak when a large amount of
3-O-35S-sulfated oligosaccharides (200 pmol) were injected on
DEAE-NPR-HPLC.
Determination of the Binding of 3-O-Sulfated HS Oligosaccharides to
gD—The assay for determining the binding of 3-O-sulfated HS oligo-
saccharides to gD was carried out by an immunoprecipitation procedure
using gD and anti-gD monoclonal antibody as described previously but
at a lower pH (13). Briefly, 3-O-sulfated HS (1–10 pmol) was incubated
in 50 l of buffer containing 50 mM MES and 0.01% Triton, pH 6
(binding buffer), and 2 mg/ml gD at room temperature for 30 min. The
anti-gD monoclonal antibody DL6 (5 l) was added and incubated at
4 °C for 1 h followed by addition of the protein A-agarose gel (80 l of 1:1
slurry) and agitated at 4 °C for an additional hour. The protein A-
agarose gel (Pierce) was then washed with 0, 50, 150, and 500 mM NaCl
in the above binding buffer.
The binding affinity between 3-O-sulfated oligosaccharides and gD
was determined using affinity co-electrophoresis, as previously de-
scribed (13). The gel was dried and analyzed on a PhosphorImager
(Amersham Biosciences, Storm 860) to determine the migration of
[35S]oligosaccharides. The 35S-intensity was plotted against the migra-
tion distance through the separation zone to define the distance mi-
grated in the presence or absence of gD.
Determination of the Structure of a gD-binding Octasaccharide
Enzymatic and Nitrous Acid Degradation of Octasaccharides—The
conditions for digestion with 4,5-glycuronidase and HS glycuronate-2-
sulfatase were described elsewhere (27). The conditions for the nitrous
Structural Characterization of the gD-binding Site 33457
acid degradations under pH 1.5 and 4.5 were described in a prior
publication (8). The degraded octasaccharide was analyzed by
DEAE-NPR-HPLC.
N-Acetylation of Oligosaccharides—The oligosaccharide (5  105 to
1  106 cpm, 36–72 pmol) was dissolved in 20 l of a solvent containing
N,N-dimethylformamide and triethylamine (1:1, v/v) and 5 l of acetic
anhydride, and incubated on ice for 1 h. Tris (20 l of 50 mM) was then
added and the reaction mixture was incubated on ice for an additional
hour. The sample was then diluted with 10 volumes of water and
dialyzed against 50 mM ammonium bicarbonate using a MWCO 3,500
membrane.
Derivatizations—Derivatizations were carried out by reacting 5 l of
oligosaccharide solution with 5 l of 50 mM semicarbazide and 60 mM
Tris acetic acid (pH 7.0, prepared fresh daily) for 16 h at 30 °C.
Analysis of HS Oligosaccharides Using Mass Spectrometry—Two
mass spectrometry techniques, matrix-assisted laser desorption/
ionization mass spectrometry (MALDI-MS) and nanoelectrospray
ionization mass spectrometry (nESI-MS), were employed. The
MALDI-MS spectra were acquired in the linear mode using a Persep-
tive Biosystems Voyager Elite reflectron time-of-flight instrument
fitted with a 337-nm laser as described elsewhere (28). The nESI-MS
analysis was carried out using a Micromass Quattro II with QhQ
geometry, a Z-spray source, and pulled borosilicate glass nanovials
(29). In the neutral loss scan, MS/MS spectra were obtained by
scanning Q1 and Q3 with an offset of 26.7 or 20 m/z in their scan
cycles, corresponding to the loss of sulfate from the triple or quadru-
ple charged octasaccharide, respectively (29). To obtain a high quality
nESI-MS spectrum, the purified octasaccharide was further dialyzed
against 25 mM ammonium acetate (purity of ammonium acetate is
99.9999%, Aldrich) using MWCO 13,000 hollow fiber dialysis tubing
(Spectrum). Control studies showed that 80–95% of 3-O-[35S]pen-
tasaccharide (Mr  1507) could be recovered using this dialysis
tubing.
Analysis of Oligosaccharides by Capillary Electrophoresis—The ap-
proach for the analysis of oligosaccharides followed a previously de-
scribed method with modifications (30). Briefly, the analysis was car-
ried out on a Beckman P/ACE MDQ unit using an uncoated fused silica
capillary (inner diameter  75 m; Ltot  106 cm). Hydrodynamic
injection was employed under 9.5 p.s.i. for 5 s. About 274 nl of the
sample was calculated to be injected by CE Expert software. The elec-
trolyte was a solution of 10 M dextran sulfate and 50 mM Tris-phos-
phoric acid, pH 2.5. Separation was carried out at 25 kV.
RESULTS
Isolation of the gD-binding Octasaccharide
A gD-binding octasaccharide was purified from a 3-OST-3A-
modified HS oligosaccharide library. The HS oligosaccharide
library was prepared by incubating HS with a limited amount
of heparin lyase III. The resultant material was fractionated by
a Bio-Gel P-6 column based upon the size of the oligosaccha-
rides, obtaining di-, tetra,-, . . . , dodeca-, and dodecasaccha-
FIG. 1. Purification of a gD-binding oligosaccharide by PAMN-HPLC. Panel A shows the profiles of the 3-O-35S-sulfated oligosaccharides
eluted from a protein A-agarose column with different concentrations of NaCl. The top chromatogram is the profile of the fractions that were eluted
without sodium chloride; the bottom chromatogram is the profile of the fractions that were eluted with 150 mM NaCl. Panel B shows the binding
of purified oligosaccharides and gD using an immunoprecipitation approach.
TABLE I
The binding of 3-O-sulfated oligosaccharides to gD
The binding of HS and oligosaccharides to gD was carried out at pH
6 by using an immunoprecipitation approach as described under “Ex-
perimental Procedures.”









Hexasaccharidesa Not determined 3.4
a Because 3-OST-1 sulfated hexasaccharides very poorly, we could
not obtain sufficient amount of 3-OST-1-modified hexasaccharides for
the binding experiment. Therefore, we were unable to compare the
binding of 3-OST-1-modified hexasaccharides and 3-OST-3A-modified
hexasaccharides. Nevertheless, a gD-binding octasaccharide was iso-
lated from the 3-OST-3 modified-hexasaccharide library as described in
the text.
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rides (data not shown), and a similar approach to prepare a HS
oligosaccharide library was reported by Pye and colleagues
(26). Because of the limited resolution capability of Bio-Gel P-6,
each oligosaccharide library undoubtedly contained the oligo-
saccharides with different sizes. These fractions were then
subjected to 3-OST-3A modification and assayed for gD binding
(Table I). Because 3-OST-1-modified HS does not bind to gD, we
utilized the 3-OST-1-modified oligiosaccharides as a negative
control (13). As shown in Table I, the gD-binding percentage of
3-OST-3A-modified oligosaccharides was about 3-fold higher
than that of the 3-OST-1-modified counterparts. We chose to
purify a gD-binding oligosaccharide from the 3-OST-3A-modi-
fied hexasaccharide pool based upon the following two reasons:
1) the purification of hexasaccharides or octasaccharides can be
achieved by anion exchange HPLC; 2) sequencing analysis for
hexa- or octasaccharide is significantly less complex than
larger oligosaccharides.
We purified a gD-binding oligosaccharide by successive an-
ion-exchange HPLC, PAMN-, and DEAE-NPR-HPLC. Five ma-
jor 3-O-35S-sulfated oligosaccharides were resolved by PAMN-
HPLC (data not shown). To identify which [35S]oligosaccharide
has the highest binding affinity for gD, the 3-OST-3A-modified
oligosaccharides were fractionated by an immunoprecipitation
approach as described under “Experimental Procedures.” The
eluents were analyzed by PAMN-HPLC (Fig. 1A). Comparing
the chromatograms of the 3-O-35S-sulfated oligosaccharides
eluted from protein A-agarose under different concentrations of
sodium chloride, we found that fraction D was present when
the protein A-agarose was eluted with 150 mM NaCl (Fig. 1A,
bottom chromatogram). In contrast, fraction A was present
when the protein A-agarose was eluted with the buffer without
NaCl (Fig. 1A, top chromatogram). This result suggests that
fraction D has higher affinity for gD than fraction A. As indi-
cated, it was observed that 32% of fraction D binds gD, whereas
only 9% of fraction A binds to gD (Fig. 1B). Thus, we designated
fraction D as a gD-binding oligosaccharide and fraction A as a
gD-nonbinding oligosaccharide. Fraction B and fraction C were
considered gD-nonbinding oligosaccharides, and were not sub-
ject to further structural study as their binding percentages to
gD are similar to that of fraction A (Fig. 1B). Additional 35S-
labeled molecules were eluted from the protein A-agarose col-
umn with 500 mM sodium chloride. However, those molecules
did not give sharp peaks on PAMN-HPLC. In addition, those
molecules migrated as the oligosaccharides that were much
larger than octasaccharides on Bio-Gel P-6. It is possible that
these molecules represented the 35S-labeled oligosaccharide
contaminants that were larger than octasaccharides in the
oligosaccharide library. Fraction D was further purified on
DEAE-NPR-HPLC.
To confirm the purity, fraction D was analyzed by capillary
electrophoresis using a UV 230 nm on-line detector. As shown
in Fig. 2 (bottom electrophoretogram), the octasaccharide li-
FIG. 2. The electrophoretogram of fraction D analysis with capillary electrophoresis. Purified fraction D was analyzed on capillary
electrophoresis with an on-line UV detector at 230 nm under reverse polarity conditions. The bottom electrophoretogram shows the separation of
HS octasaccharide library. The top electrophoretogram shows the separation of fraction D. The inset shows the enlarged region where fraction D
migrated.
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brary was well resolved by capillary electrophoresis, suggest-
ing that the resolution of the oligosaccharides on capillary
electrophoresis is high. Fraction D migrated predominantly
as a single peak under such conditions (Fig. 2, top electro-
phoretogram). In addition, the area of the major UV peak is
consistent with the estimated concentration of the octasac-
charide based upon the specific 35S-radioactivity. Having con-
sidered the minor UV peaks resulting from contaminants, we
calculated the purity of fraction D to be greater than 80%.
We also determined the binding affinity (Kd) between frac-
tion D and gD using affinity coelectrophoresis as described by
Lee and Lander (31). Fraction D was separated under elec-
trophoresis in an agarose gel through zones containing gD at
various concentrations (Fig. 3A). From these data, the Kd for
fraction D and gD was determined to be 18 M (Fig. 3C),
which is somewhat higher than the Kd of intact 3-O-sulfated
HS and gD (2 M) (13). We also attempted to determine the
Kd between fraction A (gD-nonbinding oligosaccharide) and
gD using this method. We failed to observe any obvious
retarded migration of fraction A, suggesting that the binding
affinity between fraction A and gD is low (Fig. 3B). We
estimated that the Kd for fraction A and gD is greater than
200 M.
Structural Characterization of Fraction D
Analysis of Fraction D by nESI-MS and MALDI-MS—The
molecular mass of fraction D was determined by both nESI-MS
and MALDI-MS. The nESI-MS spectrum of fraction D is shown
in Fig. 4. The sample shows a triple charged ion, [M-3H]3, at
m/z 648.8 and a strong quadruple charged ion, [M-4H]4, at m/z
486.4 (Fig. 4A). We confirmed that the signals at m/z 648.8 and
486.4 contain sulfate groups by using neutral loss experiments
as described in a prior publication (29). Briefly, the isolated
ions were sequentially admitted to a collision cell filled with
argon under controlled energy conditions, resulting in limited
dissociation. The linkage between the sulfate and the hydroxyl
group is labile, and the products from a series of sulfate losses
within the collision cells are common. The experiments were
designed to detect molecular ions that lose 20 m/z (correspond-
ing to the loss of the sulfate from the quadruple charged oligo-
saccharide), and signals were detected 486.4, 491.9, and 495.9
m/z (Fig. 4B). Similarly, neutral loss scans looked for oligosac-
charides that lose 26.7 m/z (corresponding to the loss of the
sulfate from the triple charged oligosaccharide), and signals
were detected at 648.9, 656.0, and 661.4 m/z (Fig. 4C). Taken
together, these data suggest that the signals at 648.8 and 486.4
m/z were likely derived from triple and quadruple charged
oligosaccharides, respectively. From these data, the molecular
mass of fraction D was calculated to be 1949.5 Da (from
the triple charged ion, the molecular mass of fraction D is
648.8  3  3  1949.4; from the quadruple charged ion, the
molecular mass of fraction D is 486.4  4  4  1949.6).
The determined molecular mass for fraction D was very close
to the theoretical value (1950.1 Da) for a heptasulfated octasac-
charide with one N-acetylated glucosamine residue
(UA(UA)3(GlcN)3 GlcNAc(SO3H)7, C50H78O62N4S7).
2
We also determined the molecular mass of fraction D by
using MALDI-MS. MALDI-MS requires that a complex be-
tween fraction D and a synthetic peptide (Arg-Gly)19-Arg be
formed (32). After subtracting the contribution of the proto-
nated peptide, the molecular mass of fraction D was calculated
to be 1951.2 Da (spectrum not shown).3 Thus, the result of
MALDI-MS is consistent with the result of nESI-MS.
Sequencing Analysis of Fraction D—Because we had demon-
strated that fraction D is a heptasulfated octasaccharide with
an N-acetylated glucosamine residue, we conducted sequencing
analysis to identify the position of the sulfate groups in each
residue and to determine the identity of uronic acid residues
(i.e. glucuronic acid or iduronic acid).
[35S]Disaccharide Analysis of Fraction D—A disaccharide
analysis was performed to determine the identity of the disac-
charide with a 3-O-[35S]sulfate group. In this experiment, frac-
2 We calculated the molecular weight of fraction D based on 32S,
because [35S]sulfate represents less than 0.4% of total 3-O-sulfation.
3 The molecular mass of fraction A was determined to be 1834 Da by
MALDI-MS. The molecular mass is consistent with an octasaccharide
with five sulfate groups and two N-acetylated glucosamine residues.
FIG. 3. Binding constant (Kd) for the
interaction between fraction D and
gD-1. Panel A presents the autoradio-
graph of the agarose gel in which purified
fraction D was subjected to electrophore-
sis through zones containing gD-1 at the
concentrations indicated. Approximately
30,000 cpm (3  1012 mol)/lane of
[35S]fraction D was loaded in each sepa-
ration zone. Panel B presents the autora-
diograph of the agarose gel in which pu-
rified [35S]fraction A (15,000 cpm, 1.5 
1012 mol/lane) was subjected to electro-
phoresis through zones containing gD at
the concentrations indicated. Panel C rep-
resents the plot of R/[gD]total versus R,
where the retardation coefficient, R 
(M0-M)/M0. M0 is the migration of free
[35S]fraction D, and M is the observed mi-
gration of [35S]fraction D in the presence
of gD-1. Assuming that [35S]fraction D
and gD-1 form a 1:1 complex and gD-1 is
in great excess, this plot should yield a
straight line with a slope of 1/Kd accord-
ing to the Scatchard equation. The linear
coefficient value of the plot is 0.98, and
the calculated Kd is 18 M. Because there
was no obvious retardation for fraction A
under the assay conditions, we were un-
able to perform a graphical analysis to
determine the binding constant (Kd) be-
tween gD and fraction A.
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tion D was degraded with nitrous acid at pH 1.5 followed by
sodium borohydride reduction. The resultant disaccharides
were analyzed by reverse-phase ion pairing HPLC (11). We
found that nearly 90% of the [35S]disaccharide was IdoUA2S-
[3-35S]AnMan3S6S (Fig. 5).4 The result suggests that the 3-O-
35S-sulfation site is present in a disaccharide with a structure
of -IdoUA2S-GlcNH23S6S-, provided that a previous report (11)
demonstrated that 3-OST-3A sulfates an N-unsubstituted glu-
cosamine residue.
Sequencing Analysis from the Reducing End—Fraction D
was reacted with semicarbazide to form a semicarbazone at
the reducing end, as illustrated in Fig. 6C (30). This reaction
increases the molecular mass of the oligosaccharide by 56.1
Da. The semicarbazone moiety serves as a mass tag during
sequence analysis to differentiate oligosaccharides derived
from the reducing end of the parent compound. By capillary
electrophoresis, we confirmed that greater than 95% of Frac-
tion D was labeled under the standard derivatization condi-
tions (data not shown). The molecular mass of the derivatized
fraction D was determined to be 2008 Da using MALDI-MS
(Fig. 6A), confirming that the tag was present. Upon treat-
ment of the derivatized oligosaccharide with heparin lyase II,
a tetrasaccharide of mass 1131.1 was observed (Fig. 6B). This
mass corresponds to a pentasulfated tetrasaccharide labeled
with the mass tag (1075.0  56.1 Da). By capillary electro-
phoresis, this tetrasaccharide had an identical migration
time to the standard UA2S-GlcNS-IdoA2S-GlcNH23S6S-
semicarbazide (11) (data not shown). We further strength-
ened the conclusion by demonstrating that residue 4 (UA2S)
carries the 2-O-sulfate group as described below.
We examined the susceptibility of the reducing end tetrasac-
charide (residues 1–4) to HS glycuronate-2-sulfatase (Fig. 7).
The reducing end tetrasaccharide was prepared by subjecting
the octasaccharide to digestion by heparin lyase II, because it
was reported that the tetrasaccharides containing a 3-O-sul-
fated glucosamine residue is resistant to digestion (11, 33).
Comparing the elution times of the undigested and digested
reducing end tetrasaccharide, we found that the tetrasaccha-
ride was susceptible to HS glycuronate-2-sulfatase digestion.
Thus, the reducing end residue (residue 4) of the tetrasaccha-
ride is a 2-O-sulfated 4,5-uronic acid, provided that HS glycu-
ronate-2-sulfatase specifically reacts with this residue (24).5
Taken together, these results demonstrate that fraction D con-
tains a tetrasaccharide with a structure of UA2S-GlcNS-
4 Two minor [35S]peaks were also observed, representing [35S]sulfate
and IdoUA2S-AnMan3S, respectively. The IdoUA2S-AnMan3S is prob-
ably the partial desulfated IdoUA2S-AnMan3S6S because of nitrous
acid degradation or the product of the minor contaminants in the
fraction D.
5 It should be noted that we identified the positions of five sulfate
groups in the reducing end tetrasaccharide to this end. Because low-pH
nitrous, pH 1.5, degradation of fraction D resulted in a trisulfated
disaccharide (IdoUA2S-AnMan3S6S) (Fig. 5), the octasaccharide must
contain a trisaccharide carrying four sulfate groups with a structure of
–GlcNS-IdoUA2S-GlcNH23S6S–. Another sulfate group is located at
the 2-OH position of residue 4.
FIG. 4. nESI-MS spectra of fraction D. The mass spectrum of fraction D is shown in panel A. A neutral loss scan for the loss of 20 m/z is shown
in panel B. A neutral loss scan for the loss of 26.7 m/z is shown in panel C.
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IdoUA2S-GlcNH23S6S; the location of this tetrasaccharide is
from residue 1 to 4.6
Sequencing Analysis from the Nonreducing End—Sequenc-
ing from the nonreducing end was accomplished by using var-
ious exoenzymes followed by chromatography on DEAE-NPR-
HPLC. The goal of the nonreducing sequencing analysis was to
identify the position of the two remaining sulfate groups within
residues 5–8, given that five sulfate groups were determined to
be present on residues 1–4.
The sequencing strategy from the nonreducing end and the
experimental data are shown in Fig. 8. The retention time of
fraction D was shifted from 46 to 38 min after digestion with
HS 4,5-glycuronidase (Fig. 8B). This result suggests that a
4,5-unsaturated uronic acid residue was at the nonreducing
end, based upon the substrate specificity of HS glycuronidase
(24, 34). The minor unknown product was removed prior to the
sulfamidase digestion. The resultant heptasaccharide was sus-
ceptible to digestion by sulfamidase, as observed by a shift in
the retention time from 38 to 30 min on DEAE-NPR-HPLC
(Fig. 8C), suggesting that it contains an N-sulfated glucosa-
mine residue. The sample was then subjected to N-acetylation
by incubating with acetic anhydride to generate an N-acety-
lated glucosamine residue at the nonreducing end, because
-N-acetylglucosaminidase does not react with an N-unsubsti-
tuted glucosamine. A successful N-acetylation on the N-unsub-
stituted glucosamine residue of the heptasaccharide after
treatment with acetic anhydride was confirmed, as a shift in
the retention time on DEAE-NPR-HPLC was observed (Fig.
8D). The N-acetylated heptasaccharide was susceptible to -N-
acetylglucosaminidase digestion as a shift of retention time
from 33 to 38 min was observed (Fig. 8E).7 At this point,
fraction D was converted to a hexasaccharide carrying six
sulfate groups. The undigested product was removed after pu-
rification by DEAE-NPR-HPLC. The resultant hexasaccharide
was susceptible to iduronate-2-sulfatase digestion as the reten-
tion time was shifted from 38 to 27 min after treatment (Fig.
8F). Furthermore, the resultant oligosaccharide was suscepti-
ble to -iduronidase digestion (Fig. 8G). The results from the
susceptibilities to digestions by iduronate-2-sulfatase and
-iduronidase suggest that residue 6 is a 2-O-sulfated iduronic
acid residue. The positions of all sulfate groups were therefore
determined. The proposed structure is: UA-GlcNS-IdoUA2S-
GlcNAc-GlcUA2S (or IdoUA2S)-GlcNS-IdoUA2S-GlcNH23S6S.
To further confirm the results from nonreducing sequencing
analysis, fraction D was treated with heparin lyase II and
analyzed by capillary electrophoresis. A tetrasaccharide (resi-
dues 1–4) and two disaccharides were generated after diges-
tion as the tetrasaccharide carrying the 3,6-disulfated glucosa-
mine was not susceptible to digestion by heparin lyase II as
described above. Enzyme-produced tetrasaccharide coeluted
with a tetrasaccharide standard with a structure of UA-Gl-
cNS-IdoUA2S-GlcNH26S3S (corresponding residues 1–4, data
not shown). The preparation of this tetrasaccharide standard
was published previously (11). In addition, two resultant di-
saccharides were identified to be UA-GlcNS and UA2S-Glc-
NAc (data not shown). Again, the results from heparin lyase
II digestion are consistent with the proposed structure for
fraction D.
We attempted to determine the identity of residue 4. As
described above, we concluded that residue 4 carries a 2-O-
sulfate group. To address the identity of residue 4, a tetrasac-
charide, representing residues 1–4, was prepared by deacety-
lation followed by nitrous acid degradation at pH 4.5.8 The
resultant tetrasaccharide, which carried a 2-O-sulfated uronic6 We also attempted to prove the presence of an N-unsubstituted
glucosamine residue at the reducing end by treating the octasaccharide
with nitrous acid at pH 4.5 followed by sodium borohydride reduction.
The molecular mass of the resultant octasaccharide was determined
using nESI. We found that the molecular mass of the high pH nitrous-
treated octasaccharide is 1855 Da, a loss of 95 Da. A reduction of 95 Da
is consistent with the deamination (15 Da) and a loss of sulfate (80
Da). Our result suggested that desulfation also occurred during nitrous
acid, pH 4.5, treatment or during analysis of nESI-MS. Nevertheless,
the result is consistent with the fact that the octasaccharide contains an
N-unsubstituted glucosamine residue.
7 We observed that only 50% of the heptasaccharide was digested by
-N-acetylglucosaminidase. A similar incomplete digestion was ob-
served for a pentasaccharide with a structure of GlcNAc-GlcUA-[3-
35S]GlcNS3S6S-IdoUA2S-GlcNS6SOMe digested by -N-acetylglu-
cosaminidase. The pentasaccharide was prepared by incubating acetic
anhydride with a pentasaccharide with a structure of GlcNH2-GlcUA-
[3-35S]GlcNS3S6S-IdoUA2S-GlcNS6SOMe. The latter pentasaccharide
was generated from GlcNS6S-GlcUA-[3-35S]GlcNS3S6S-IdoUA2S-
GlcNS6SOMe (29) by sequential digestions by glucosamine-6-sulfatase
and sulfamidase.
8 The tetrasaccharide was prepared by incubating purified fraction D
with hydrazine for deacetylation. The deacetylated octasaccharide was
degraded by nitrous acid at pH 4.5 and sodium borohydride reduction.
The resultant oligosaccharide migrated as a tetrasaccharide on Bio-Gel
P-6, and was purified by DEAE-NPR HPLC. The proposed structure of
this tetrasaccharide is UA2S-GlcNS-IdoUA2S-AnMan3S6S.
FIG. 5. RPIP-HPLC chromatogram
of low-pH nitrous acid degraded frac-
tion D. Fraction D was treated with ni-
trous acid at pH 1.5 followed by sodium
borohydride reduction. The resultant dis-
accharides were resolved on RPIP-HPLC.
Arrows indicate the elution positions of
the disaccharide standards. 1 represents
IdoUA2S-AnMan3S; 2 represents GlcUA-
AnMan3S6S; 3 represents IdoUA2S-
AnMan6S; and 4 represents IdoUA2S-
AnMan3S6S.
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acid residue at the nonreducing end, was subjected to exolytic
enzyme digestions. We found that the tetrasaccharide was
resistant to the digestions by iduronate-2-sulfatase, -iduroni-
dase, and -glucuronidase (data not shown). The result sug-
gests that residue 4 is a 2-O-sulfated glucuronic acid as it is
known to be unsusceptible to digestions by any of these enzymes.
It is known that glucuronate-2-sulfatase specifically removes the
sulfate from 2-O-sulfated glucuronic acid residue (36). However,
because of the unavailability of glucuronate-2-sulfatase, we could
not determine whether the resultant tetrasaccharide was suscep-
tible to digestion. We also found that fraction D was resistant to
heparin lyase II mutant (C348A) digestion (data not shown). The
mutated enzyme cleaves glycosidic linkages containing unsul-
fated uronic acids but not those containing sulfated iduronic
acids (35) and sulfated glucuronic acids.9 The latter result hinted
that residue 4 is a 2-O-sulfate glucuronic acid residue. However,
we also found that an octasaccharide, containing the linkage of
9 Z. Shriver and R. Sasisekharan, unpublished observation.
FIG. 6. MALDI-MS spectra of the reducing end sequencing analysis of fraction D. Panel A shows the mass spectrum of the analysis of
the intact octasaccharide after derivatization. The observed mass of 2008.3 is consistent with a single label attached to the reducing end. Panel B
shows the MALDI-MS spectrum of the end-labeled tetrasaccharide arising from heparin lyase II digestion of the semicarbazide-labeled octasac-
charide. Panel C shows the chemical reactions of the reducing end sequencing analysis. P represents peptide (Arg-Gly)19-Arg; Sac  P represents
the complex of peptide and octasaccharide.
Structural Characterization of the gD-binding Site 33463
–GlcNAc-IdoUA2S-, was resistant to digestion by the heparin
lyase II mutant (C348A).10
DISCUSSION
HS is a common receptor for numerous viruses. It is believed
that the defined sulfated sequences determine the specificity
for herpes simplex virus (13, 19, 20). Because of the structural
complexity of HS, the structural specificity of HS-based receptors
is still unknown. It is apparent that understanding the relation-
ship between the saccharide sequences and their activities in
promoting viral infection will permit us to delineate HS-assisted
viral infections at the molecular level. A previous study has
shown that the interaction of 3-O-sulfated HS, generated by
3-OST-3 but not by 3-OST-1, interacts with gD to induce the
entry of HSV-1 into target cells (13). In the present study, a
gD-binding octasaccharide was prepared and purified from a HS
oligosaccharide library that was modified by 3-OST-3. The se-
quence of the isolated gD-binding site is UA-GlcNS-IdoUA2S-
GlcNAc-UA2S-GlcNS-IdoUA2S-GlcNH23S6S. To our knowledge,
this structure has not been previously reported in HS or heparin.
As expected, a 3-O-sulfated N-unsubstituted glucosamine resi-
due was found (residue 1). The result is consistent with the
previously characterized substrate specificity of 3-OST-3A (11).
The binding affinity between gD and the purified octasaccha-
ride was determined to be 18 M. We noted that the gD-binding
affinity of the octasaccharide is about 10-fold lower than that of
the intact 3-OST-3-modified HS. Two possibilities may contribute
to the lower binding affinity. First, two domains in gD for binding
to 3-O-sulfated HS were predicted by Carfi and colleagues (21). It
is possible that the HS polysaccharide interacts with both sites,
whereas the octasaccharide is insufficiently large to bind at both
sites. Second, both - and -anomeric isomers of octasaccharides
are likely generated by heparin lyase III depolymerization. The
binding affinities of the - and -anomeric isomers of the octasac-
charide may be different. At the polysaccharide level, the gluco-
samine residue is present in only the -form.
The results from the sequencing analysis of the octasaccha-
ride suggested that residue 4 is a 2-O-sulfated uronic acid. Two
lines of evidence hinted that residue 4 is a 2-O-sulfated glucu-
ronic acid residue. First, our results showed that residue 4 is
resistant to digestion by -glucuronidase, -iduronidase, or
iduronate-2-sulfatase. We noted that 2-O-sulfated glucuronic
acid is resistant to digestions by these enzymes. Second, the
octasaccharide is susceptible to the wild type heparin lyase II
digestion, but not susceptible to digestion by a heparin lyase II
mutant (C348A). Heparin lyase II cleaves the linkages that
contain 2-O-sulfated glucuronic acid residue, whereas the mu-
tated enzyme, heparin lyase II (C348A), does not cleave this
type of linkage.11 In addition, a previous report demonstrated
10 In addition to the results presented in a prior publication (35), we
tested the susceptibilities of three oligosaccharides to the digestion by
heparin lyase II mutant (C348A). Two of them were tetrasaccharides
with structures of UA2S-GlcNS6S-GlcUA2S-GlcNS and UA2S-
GlcNS6S-GlcUA2S-GlcNS6S (43). One is an octasaccharide with a
structure of UA2S-GlcNAc-IdoUA2S-GlcNAc-IdoUA2S-GlcNAc-
IdoUA2S-GlcNAc (38). All three of the oligosaccharides were resist-
ant to the digestion.
11 We failed to detect any 3H-labeled monosulfated disaccharides
from the high pH (4.5) and low pH (1.5) nitrous acid-degraded fraction
D (10 pmol) followed by [3H]sodium borohydride (5–15 Ci/mmol) reduc-
tion despite the fact that IdoUA2S-[3H]AnMan3S6S was detected. It is
mainly because of 3H-labeled contaminants in the sodium [3H]borohy-
dride. Those contaminants were eluted near the region where
3H-labeled monosulfated disaccharides were eluted on RPIP-HPLC.
FIG. 7. DEAE-NPR-HPLC chromatograms of the reducing end tetrasaccharide (residues 1–4) before and after HS glycuronate-2-
sulfatase digestion. The reducing tetrasaccharide was obtained by subjecting fraction D to heparin lyase II digestion. The resultant tetrasac-
charide was then digested with HS glycuronate-2-sulfatase. Panel A shows the chromatogram of the undigested tetrasaccharide. Panel B shows
the chromatogram of glycuronate-2-sulfatase-digested tetrasaccharide. Panel C depicts action of the HS glycuronate-2-sulfatase digestion.
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FIG. 8. Nonreducing end sequencing analysis of fraction D. Panels A–G shows the profiles of enzymatically digested fraction D on
DEAE-NPR-HPLC. Between the steps of the sequencing analysis, the designated product was purified by DEAE-NPR-HPLC followed by desalting.
The action of the enzymatic digestions at each sequencing step is also indicated. The “minor unknown product” (panel B) was removed by HPLC
before sulfaminidase digestion. Likewise, the “undigested material” (panel E) was removed HPLC before iduronate-2-sulfatase digestion.
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that the 2-O-sulfated glucuronic acid is present in the HS that
is isolated from bovine kidney (37). More convincing evidence is
required to conclude with certainty that residue 4 is a 2-O-
sulfated glucuronic acid. Whereas high resolution NMR spec-
troscopy could solve this question, it requires significantly
larger quantities of octasaccharide than is currently available
(38).
It is also very important to note that the disaccharide se-
quence of –GlcNAc-IdoUA2S– was specifically excluded from
the HS or heparin from mammalian cells (39). This conclusion
is based on the substrate specificity of HS epimerase that
converts glucuronic acid to iduronic acid (40). It is known that
an N-sulfated glucosamine residue that is linked to a glucu-
ronic acid at the nonreducing end is “absolutely” required for
the action of epimerase (39). Thus, the sequences of –GlcNS-
IdoUA– and –GlcNS-IdoUA2S– are present in HS, whereas,
the sequences of –GlcNAc-IdoUA- and –GlcNAc-IdoUA2S– are
not. It should be noted that the sequence of –GlcNAc-IdoUA2S–
was isolated from Achatina fulica, suggesting that the epime-
rase may have different substrate specificities from different
organisms (38).
We also noted that –GlcNAc-GlcUA2S– has not been discov-
ered in HS that is isolated from natural sources. The 2-O-
sulfated glucuronic acid residue is a rare constituent of HS, and
was found in HS isolated from the adult human cerebral cortex,
a nuclear fraction from hepatocytes, HS from bovine kidney,
and heparin from porcine intestines (41–43). This residue is
synthesized by HS 2-O-sulfotransferase, although the enzyme
preferably generates 2-O-sulfated iduronic acid (IdoUA2S) (44).
To this end, it is still not known whether the presence of a
2-O-sulfated glucuronic acid, or possibly a 2-O-sulfated idu-
ronic acid, residue is essential for gD binding. A comprehensive
study of the relationship of the saccharide sequences and gD-
binding affinity remains to be investigated when a series of
structurally defined HS oligosaccharides are available. The
structural information from this study will serve as a lead
compound for the chemical synthesis of HS oligosaccharides for
further investigation (45).
It is now widely accepted that HS contains both high and low
sulfated domains (46). The highly sulfated domains, containing
the repeating trisulfated disaccharides of –IdoUA2S-
GlcNS6S–, has been the focus of a number of studies investi-
gating HS-related biological functions. For example, the highly
sulfated domains bind to fibroblast growth factors and fibro-
blast growth factor receptors to exhibit various biological func-
tions. Furthermore, previous reports suggest that the anti-
thrombin-binding site is also located within highly sulfated
domains (27, 47). It is interesting to note that the gD-binding
octasaccharide contains two motifs with distinct sulfation lev-
els. The low sulfated domain, residues 5–8, is composed of one
sulfate group per disaccharide, and the highly sulfated domain,
residues 1–4, is composed of an average of 2.5 sulfate groups
per disaccharide. Thus, these results suggest that the gD-
binding site contains both a highly sulfated domain and a low
sulfated domain. The crystal structure of gD and HveA, a
previously characterized herpes simplex viral entry receptor,
predicts two potential 3-O-sulfated HS-binding sites (21). One
binding site is located in a deep surface pocket with only three
basic amino acid residues. This proposed binding site is very
close to the binding site of gD and HveA, suggesting that this
site might be involved in functional changes in gD. Their ob-
servation suggests that the binding of 3-O-sulfated HS to this
site might involve a small number of positive amino acid resi-
dues (from gD) and small number of negatively charged sulfate
groups (from HS). A second 3-O-sulfated HS-binding site was
identified on a relatively flat surface with numerous basic
amino acid residues. The second site is away from the HveA-
binding site on gD. Carfi and colleagues (21) suggest that the
second site in gD might provide the ionic interaction sites to
bind to 3-O-sulfated HS. It remains to be investigated at which
binding sites in gD the isolated octasaccharide interacts.
In summary, an approach to isolate and characterize an
octasaccharide that binds to gD was described. It is still not
known if this octasaccharide is the minimum necessary se-
quence for assisting HSV-1 entry into cells. Nevertheless, be-
cause the interaction of gD and 3-O-sulfated HS is a key step
for triggering the fusion of virus and cells, our study provides
valuable structural information for determining the specific
roles of HS in assisting HSV-1 infections, as well as in the
development of therapeutic agents for treating HSV-1
infection.
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